Corbus Pharmaceuticals' GAAP loss for 6M 2021 was $33.204 million, down 51% from $67.762 million in the previous year. Revenue decreased 61.7% to $0.784 million from $2.048 million a year earlier.
Corbus Pharmaceuticals' GAAP loss for 6M 2021 was $33.204 million, down 51% from $67.762 million in the previous year. Revenue decreased 61.7% to $0.784 million from $2.048 million a year earlier. 
ir.corbuspharma.com
English (US) 